Revelation Biosciences In...

0.02
0.00 (19.05%)
At close: Mar 12, 2025, 1:38 PM

Revelation Biosciences Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -0.00 -455.68 -5.32 -134.4 -897.21 -390.52K
PEG Ratio -0.00 4.56 0.10 -0.23 -0.02 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 0.00 8.24 54.52 -16.2K 428.80 -390.52K
P/FCF Ratio -0.00 -7.52 -5.11 -143.55 -6.8K n/a
P/OCF Ratio -0.00 -7.52 -5.11 -145.26 -6.8K n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a -0.17 n/a n/a
Quick Ratio 3.43 2.18 1.22 0.89 3.82 n/a
Current Ratio 3.43 2.18 1.22 0.89 3.82 n/a
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -3.19 -0.02 -10.26 120.51 -0.48 1.00
Return on Assets (ROA) -2.27 -0.01 -1.96 -5.87 -0.35 -0.16
Return on Capital (ROIC) -1.69 -1.3 -10.32 120.14 -0.04 1.00
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a